Antineuronal antibodies against neurotransmitter receptors and synaptic proteins in schizophrenia: current knowledge and clinical implications

CNS Drugs
Johann SteinerB Bogerts

Abstract

When Eugen Bleuler coined the term 'schizophrenia' he believed that various causes of illness may underlie this disease. Currently, neurodevelopmental abnormalities and consecutive impairments in dopaminergic and glutamatergic neurotransmission are considered as major causes of schizophrenia. However, there are various indications for involvement of immune processes, at least in subgroups of patients. Circulating antineuronal antibodies provide a promising link between the well-described disturbances in neurotransmission and the immune hypothesis of schizophrenia. This review summarizes important studies that have examined the role of glutamate, dopamine, acetylcholine and serotonin receptor autoantibodies, and other antineuronal antibodies against synaptic proteins in the serum of patients diagnosed with schizophrenia. Currently, it is not known whether the presence of antineuronal antibodies in blood should be considered as a causal or disease-modulating factor in schizophrenia. Due to emerging evidence regarding the important role of the blood-brain barrier, combined testing of serum and cerebrospinal fluid is likely to be more appropriate to answer this question than pure serum analyses. We suggest implementation of such te...Continue Reading

References

Sep 1, 1988·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A Carlsson
Jan 1, 1987·Journal of Neural Transmission·A von KirchbachH H Kornhuber
Jan 1, 1995·Clinical Microbiology Reviews·R H Yolken, E F Torrey
May 1, 1994·Schizophrenia Research·S MukherjeeR Reddy
Jun 18, 1998·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·D Hinze-SelchT Pollmächer
Jul 2, 1998·Neuropsychobiology·M RothermundtH Kirchner
Jul 17, 2001·British Journal of Pharmacology·G LombardiR Fantozzi
Sep 5, 2002·Nature Reviews. Neuroscience·Maiken NedergaardAnker J Hansen
Sep 11, 2003·Journal of Neuroimmunology·Susumu TanakaNobuyuki Amino
Jan 1, 1963·Acta Pharmacologica Et Toxicologica·A CARLSSON, M LINDQVIST
Aug 4, 2004·Archives of General Psychiatry·Alan S BrownEzra S Susser
Nov 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rodrigo PachecoRafael Franco
Nov 7, 2006·Schizophrenia Bulletin·E Fuller TorreyRobert H Yolken
Feb 17, 2007·Journal of Neuroimmunology·Rodrigo PachecoRafael Franco
Aug 16, 2008·Brain Research Reviews·Handan Gunduz-Bruce
Aug 30, 2008·Journal of Neuroscience Methods·Galina P KirillovaMichael M Vanyukov
Feb 27, 2009·Schizophrenia Research·Michelle J ChandleyBarney E Miller
Apr 1, 2009·International Immunology·Kazuhisa NakanoSho Matsushita
May 9, 2009·Nature Reviews. Immunology·Betty DiamondBruce T Volpe
Jul 3, 2009·Nature·Hreinn StefanssonDavid A Collier
Oct 20, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Janine DoorduinHans C Klein
Jan 29, 2010·European Archives of Psychiatry and Clinical Neuroscience·Johann SteinerBernhard Bogerts
Feb 2, 2010·Der Nervenarzt·H PrüssK-P Wandinger
Aug 19, 2010·Nature Reviews. Neuroscience·Franz X Vollenweider, Michael Kometer
Oct 26, 2010·Journal of Neurology·Michael S ZandiBelinda R Lennox
Dec 4, 2010·Clinical Chemistry·William E Winter, Desmond A Schatz
Dec 18, 2010·Lancet Neurology·Josep DalmauRita Balice-Gordon
Jun 7, 2011·Biological Psychiatry·Brian J MillerBrian Kirkpatrick
Jun 29, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Johann SteinerAye-Mu Myint
Jul 15, 2011·Schizophrenia Research·Georg JuckelRainer J Wolf
Dec 24, 2011·The American Journal of Psychiatry·Michael E BenrosPreben B Mortensen
Jun 9, 2012·Nature Reviews. Neuroscience·Robert SchwarczHui-Qiu Wu
Jul 7, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·K Bechter
Aug 10, 2012·Journal of Leukocyte Biology·Wouter BeumerHemmo A Drexhage
Oct 4, 2012·The American Journal of Psychiatry·Joseph C MasdeuJosep Dalmau
Oct 23, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Johann SteinerBernhard Bogerts
Nov 28, 2012·Schizophrenia Research·Marie Pierre ManitzRainer Wolf

❮ Previous
Next ❯

Citations

Sep 25, 2015·Brain, Behavior, and Immunity·Madlen LoebelCarmen Scheibenbogen
Sep 19, 2015·Open Biology·Evgeny A ErmakovGeorgy A Nevinsky
Aug 26, 2016·The Journal of Comparative Neurology·Minela HadzicPetra Wahle
Dec 23, 2015·International Journal of Molecular Sciences·Holger SteinbergHubertus Himmerich
May 9, 2018·Biochemistry. Biokhimii︠a︡·E A ErmakovG A Nevinsky
Dec 5, 2018·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Johann SteinerPeter Falkai
Jan 18, 2018·IUBMB Life·Evgeny A ErmakovGeorgy A Nevinsky
Jul 28, 2019·The Australian and New Zealand Journal of Psychiatry·Alexander E RyanJudith M Greer
Sep 26, 2020·Frontiers in Psychiatry·Karl Bechter
May 31, 2016·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·L P SmirnovaS A Ivanova
Oct 20, 2018·Neuropsychobiology·Ewa Ferensztajn-RochowiakJanusz K Rybakowski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Related Papers

The British Journal of Psychiatry : the Journal of Mental Science
M Bleuler
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
Johann SteinerAye-Mu Myint
Schweizerische medizinische Wochenschrift
L BINSWANGER
Progress in Neuro-psychopharmacology & Biological Psychiatry
Kenji Hashimoto
© 2022 Meta ULC. All rights reserved